Changchun GeneScience Pharmaceutical Co., Ltd. (GenSci), founded in 1997, is a subsidiary of Changchun High-Tech Industries (Group) Co., Ltd. (stock code 000661). GenSci is the world’s only provider of a full range of recombinant human growth hormone products and leads global sales in this segment. The company operates an integrated value chain for innovative drugs.
GenSci expands its portfolio beyond pediatric and women’s health into endocrinology, immunology, and oncology. The company maintains a dedicated research team and five technology platforms backed by significant R&D investment to address unmet clinical needs and advance candidates from discovery to clinical application.
GenSci integrates R&D, production, marketing, and services under global excellence standards. It deploys strategic teams in the USA, Europe, and Singapore to deliver healthcare solutions worldwide.